Related Experiment Video
Updated: Jul 16, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004
1Epidemiology and Disease Surveillance Unit, Texas Department of State Health Services, Austin, Texas 78756, USA. mathias.forrester@dshs.state.tx.us
Insights
Most proton pump inhibitor exposures, especially in children, can be safely managed at home. This study analyzed 2943 reported exposures, finding favorable outcomes in most cases.
Area of Science:
- Toxicology
- Pharmacology
- Public Health
Background:
- Limited data exists on managing adverse proton pump inhibitor (PPI) exposures.
- PPIs are widely used medications, increasing the potential for accidental exposures.
- Understanding exposure patterns is crucial for developing effective management strategies.
Purpose of the Study:
- To analyze the distribution and characteristics of proton pump inhibitor exposures reported to Texas poison control centers.
- To compare pediatric and adult patient demographics, exposure circumstances, and outcomes.
- To identify trends in PPI-related adverse events and their management.
Main Methods:
- Retrospective analysis of 2943 proton pump inhibitor exposure cases reported to Texas poison control centers from 1998 to 2004.
- Categorization of exposures by patient age (pediatric vs. adult), substance involved (PPI alone vs. co-exposures), and other demographic and clinical factors.
- Comparison of clinical characteristics and management outcomes between pediatric and adult populations.
Main Results:
- Proton pump inhibitor (PPI) exposures accounted for a significant number of reported cases, with 62% involving PPIs alone.
- Pediatric patients (age <= 5 years) constituted the majority (66%) of PPI-alone exposures.
- Significant differences were observed between pediatric and adult patients regarding gender, exposure reason, site, management, clinical outcomes, and treatments.
Conclusions:
- The majority of potentially adverse proton pump inhibitor exposures reported to poison control centers can be successfully managed at home with favorable outcomes.
- Age is a significant factor influencing the characteristics and management of PPI exposures.
- Further research into specific adverse effects and targeted interventions for pediatric PPI exposures may be warranted.
Abstract:
There is little information on the management of potentially adverse exposures to proton pump inhibitors. This study examined the distribution of 2943 proton pump inhibitor exposures reported to Texas poison control centers during 1998-2004. In particular comparisons were made between exposures among pediatric (age < or =5 yr) and adult (age > or =20 yr) patients. Of the total exposures, 1813 (62%) were to the proton pump inhibitor alone. Of exposures to proton pump inhibitors alone, 66% were age < or =5 yr, 7% 6-19 yr, and 27% > or =20 yr. Pediatric and adult patients differed with respect to patient gender, exposure reason, exposure site, management site, final medical outcome, report of specific adverse clinical exposures, and listed treatments. Proton pump inhibitor exposures differed with patient age. In the majority of instances, potentially adverse proton pump inhibitor exposures reported to poison control centers may be successfully managed at home with favorable outcome.
More Related Videos
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies
Prevention of Further Absorption of Poison
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...

